RxDoctor Payments Data

Lyn Dea, DO

Family Medicine · Annapolis, MDNPI 1063413599

Payments from drug & device makers

$8,155in general payments, 2019–2025

Across 468 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$923
  • Pfizer$773
  • AstraZeneca$495
  • Lilly USA, LLC$406
  • GSK$390
  • plus $4K from 46 others

What the payments were for

  • Food & beverage$8,05599%
  • Education$1001%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,155 in reported general payments places this provider in the 90th percentile of 1,193 family medicine providers in Maryland.

See all family medicine providers in Maryland

Medicare billing

Part B allowed, 2024
$204,426
Medicare patients
561
Services billed
4,845

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$84,310
MounjaroTirzepatide55$57,592
EliquisApixaban52$53,187
JanuviaSitagliptin Phosphate33$49,539
JardianceEmpagliflozin29$42,258
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$19,473
FarxigaDapagliflozin Propanediol12$18,981
XareltoRivaroxaban11$14,536
NexiumEsomeprazole Magnesium12$6,498
Rosuvastatin Calcium260$6,175
Metoprolol Succinate241$4,643
SynthroidLevothyroxine Sodium48$3,306
Atorvastatin Calcium220$3,269
Olmesartan Medoxomil106$3,050
PaxlovidNirmatrelvir/Ritonavir23$2,797

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$923$84,31068 claims
Lilly USA, LLCMounjaro$406$57,59255 claims
PfizerEliquis, Paxlovid$773$55,98575 claims
MerckJanuvia$276$49,53933 claims
Boehringer IngelheimJardiance$338$42,25829 claims
AstraZenecaFarxiga, Nexium$495$25,47924 claims
GSKTrelegy Ellipta$390$19,47327 claims
Johnson & JohnsonXarelto$258$14,53611 claims
AbbVieSynthroid, Armour Thyroid$1,427$4,47560 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$2,118271 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,193 family medicine providers in Maryland.

Other family medicine in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →